<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/ambros-aims-to-revive-neridronate-for-crps-with-precision-medicine-GNWR34AG7RC2DFJPZZ2RZXRRBQ/</loc><lastmod>2026-04-05T16:39:44.572Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-05T16:39:44.572Z</news:publication_date><news:title><![CDATA[Ambros Aims To Revive Neridronate For CRPS With Precision Medicine]]></news:title></news:news><image:image><image:loc>https://insights.citeline.com/resizer/C8MT8e5TA694KUvjWixt7szDmqc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DBKZ3TY6VNHM5KJGG3FZSGFVXQ.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/biosimilars-and-generics/generics/hatch-waxman-repairs-could-help-fight-serial-patent-litigations-SCZAB2SCKJG3FHRJNPVPRJYTTI/</loc><lastmod>2026-04-05T16:35:54.159Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-05T16:35:54.159Z</news:publication_date><news:title><![CDATA[Hatch-Waxman Repairs Could Help Fight Serial Patent Litigations]]></news:title></news:news><image:image><image:loc>https://insights.citeline.com/resizer/wzdPy2ETYn-NqqEPUBADBmpRiPw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/TE3XOEWQ3JBD5LBYC35VVFZBNA.jpeg</image:loc><image:caption><![CDATA[CAPPA has proposed reforms to limit serial patent litigation.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/companies/nanjing-miracle-biotech-co-ltd</loc><lastmod>2026-04-05T00:01:17.652Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-05T00:01:17.652Z</news:publication_date><news:title><![CDATA[Nanjing Miracle Biotech Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/lyncbio-therapeutics-coltd</loc><lastmod>2026-04-05T00:00:48.051Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-05T00:00:48.051Z</news:publication_date><news:title><![CDATA[Lyncbio Therapeutics Co.,Ltd.]]></news:title></news:news></url></urlset>